⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALGS News
Aligos Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
ALGS
Aligos Therapeutics Enters into Exclusive License Deal with Xiamen Amoytop Biotech Co., Ltd. to Develop and Commercialize Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection
globenewswire.com
ALGS
Form 8-K
sec.gov
ALGS
Aligos Therapeutics Announces First Interim Analysis Results from the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium in Participants with Chronic Hepatitis B Virus Infection and Grant of FDA Fast Track Designation
globenewswire.com
ALGS
Algenesis Cuts Carbon Footprint by Up to 65% with Soleic® Bio-Based Materials
prnewswire.com
ALGS
ECU Worldwide presenta l'espansione di XLERATE 2.0 per evitare le interruzioni nella catena di fornitura tra Europa e Asia
businesswire.com
ALGS
Unanet and Algorithms Software Expand Partnership to North America, Giving Construction Companies End-to End Capabilities From Opportunity to Delivery
prnewswire.com
ALGS
NAYA Therapeutics Announces World-Class Board of Directors
accessnewswire.com
AMGN
NVAX
MRK
CDXS
ABBV
ALGS
Form 8-K
sec.gov
ALGS
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
ALGS